The Effect of Transcatheter Injections on Cell Viability and Cytokine Release of Mononuclear Cells

References

1. 1.↵
   Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009;40:510–15. Epub 2008 Dec 18

   Abstract/FREE Full Text
2. 2.↵
   1. Savitz SI,
   2. Misra V

   . Launching intravenous bone marrow cell trials for acute stroke. Regen Med 2009;4:639–41

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Wechsler LR

   . Clinical trials of stroke therapy: which cells, which patients? Stroke 2009;40:S149–151

   FREE Full Text
4. 4.↵
   1. Savitz SI,
   2. Dinsmore J,
   3. Wu J,
   4. et al

   . Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 2005;20:101–07

   PubMedWeb of Science
5. 5.↵
   1. Fischer UM,
   2. Harting MT,
   3. Jimenez F,
   4. et al

   . Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first pass effect. Stem Cells Dev 2008;18:683–92

   CrossRef
6. 6.↵
   1. Kamiya N,
   2. Ueda M,
   3. Igarashi H,
   4. et al

   . Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci 2008;83:433–37

   CrossRefPubMed
7. 7.↵
   US Food and Drug Administration. Draft Guidance for Industry: Somatic Cell Therapy for Cardiac Disease. March 2009. US Department of Health and Human Services Web site. Vaccines, Blood, and Biologics. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ucm164265.htm. Accessed December 9, 2009
8. 8.↵
   1. Brenneman M,
   2. Sharma S,
   3. Harting M,
   4. et al

   . Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 2010;30:140–49. Epub 2009 Sep 23

   CrossRefPubMed
9. 9.↵
   1. Baker AH,
   2. Sica V,
   3. Work LM,
   4. et al

   . Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc Natl Acad Sci U S A 2007;104:3597–602

   Abstract/FREE Full Text
10. 10.↵
    1. Lipinski MJ,
    2. Biondi-Zoccai GG,
    3. Abbate A,
    4. et al

    . Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761–67

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Correa PL,
    2. Mesquita CT,
    3. Felix RM,
    4. et al

    . Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clin Nucl Med 2007;32:839–41

    CrossRefPubMed
12. 12.↵
    1. Harting MT,
    2. Cox CS,
    3. Day MC,
    4. et al

    . Bone marrow-derived mononuclear cell populations in pediatric and adult patients. Cytotherapy 2009;11:480–84

    CrossRefPubMed
13. 13.↵
    1. Tol M,
    2. Akar AR,
    3. Durdu S,
    4. et al

    . Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: an ex vivo experimental study. Cytotherapy 2008;10:98–99

    CrossRefPubMed
14. 14.↵
    1. Yoon W,
    2. Park MS,
    3. Cho KH

    . Low-dose intra-arterial urokinase and aggressive mechanical clot disruption for acute ischemic stroke after failure of intravenous thrombolysis. AJNR Am J Neuroradiol 2010;31:161–64. Epub 2009 Aug 27

    Abstract/FREE Full Text
15. 15.↵
    1. Sangchot P,
    2. Sharma S,
    3. Chetsawang B,
    4. et al

    . Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture. Dev Neurosci 2002;24:143–53

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Takahashi M,
    2. Li TS,
    3. Suzuki R,
    4. et al

    . Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 2006;291:H886–93

    Abstract/FREE Full Text
17. 17.↵
    1. Iihoshi S,
    2. Honmou O,
    3. Houkin K,
    4. et al

    . A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 2004;1007:1–9

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Heng BC,
    2. Hsu SH,
    3. Cowan CM,
    4. et al

    . Trans-catheter injection induced changes in human bone marrow-derived mesenchymal stem cells. Cell Transplant 2009;18:1111–21. Epub 2009 Jun 22

    CrossRefPubMedWeb of Science